Profile data is unavailable for this security.
About the company
MustGrow Biologics Corp. is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, it offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. It develops mustard-based organic solutions for applications in biocontrol to potentially replace harmful synthetic chemicals in preplant soil treatment and weed control, to postharvest disease control and food preservation. Its TerraSante is Organic Materials Review Institute (OMRI Listed) and Organic Input Material (OIM) registered biofertility product in California, Florida, Arizona, Idaho, Oregon, and Washington. TerraSante provides mustard proteins and carbohydrates to feed the soil microbes.
- Revenue in CAD (TTM)7.54m
- Net income in CAD-6.37m
- Incorporated2014
- Employees0.00
- LocationMustGrow Biologics Corp1005-201 1st Ave SSaskatoon S7K 1J5CanadaCAN
- Phone+1 (306) 668-2652
- Websitehttps://mustgrow.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avicanna Inc | 25.50m | -1.88m | 21.37m | 38.00 | -- | 6.44 | -- | 0.838 | -0.0165 | -0.0165 | 0.2262 | 0.0264 | 1.22 | 2.89 | 10.84 | -- | -9.02 | -61.54 | -51.98 | -226.72 | 51.95 | 49.33 | -7.37 | -150.05 | 0.3804 | -- | 0.00 | -- | 51.62 | 172.88 | 58.62 | -- | -44.27 | -- |
| Resverlogix Corp | 0.00 | -9.67m | 27.37m | 18.00 | -- | -- | -- | -- | -0.0341 | -0.0341 | 0.00 | -0.4224 | 0.00 | -- | -- | 0.00 | -91.25 | -- | -- | -- | -- | -- | -- | -- | 0.0248 | -1.30 | -- | -- | -- | -- | 54.39 | -- | -- | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -6.82m | 28.51m | -- | -- | 13.24 | -- | -- | -0.1439 | -0.1439 | 0.00 | 0.0415 | 0.00 | -- | -- | -- | -173.15 | -- | -216.52 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.87 | -- | -- | -- |
| Principal Technologies Inc | 262.84k | -4.32m | 29.19m | -- | -- | -- | -- | 111.07 | -0.1043 | -0.1072 | 0.0063 | -0.0126 | 0.2272 | -- | 1.68 | -- | -372.16 | -- | -2,615.25 | -- | -- | -- | -1,637.81 | -- | -- | -223.78 | -- | -- | -44.22 | -- | -162.24 | -- | -- | -- |
| Microbix Biosystems Inc | 18.59m | -2.25m | 30.48m | 69.00 | -- | 1.10 | -- | 1.64 | -0.0161 | -0.0161 | 0.1344 | 0.1992 | 0.4923 | 1.12 | 6.44 | -- | -5.95 | 3.86 | -6.48 | 4.37 | 53.02 | 55.92 | -12.08 | 6.37 | 5.17 | -2.23 | 0.196 | -- | -26.81 | 12.04 | -163.80 | -- | -0.4115 | -- |
| MustGrow Biologics Corp | 7.54m | -6.37m | 38.34m | 0.00 | -- | 12.34 | -- | 5.09 | -0.1206 | -0.1206 | 0.1435 | 0.0494 | 1.45 | 5.49 | 45.16 | -- | -122.84 | -54.87 | -193.93 | -66.95 | 14.51 | -- | -84.52 | -341.26 | 1.25 | -103.31 | 0.1671 | -- | -91.55 | -- | -622.18 | -- | -- | -- |
| Briacell Therapeutics Corp | 0.00 | -39.14m | 39.96m | 22.00 | -- | 0.7632 | -- | -- | -72.65 | -72.65 | 0.00 | 7.22 | 0.00 | -- | -- | 0.00 | -246.96 | -63.88 | -359.42 | -70.71 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -449.14 | -- | -- | -- |
| ZYUS Life Sciences Corp | 465.00k | -33.74m | 50.70m | 2.00 | -- | -- | -- | 109.04 | -0.4505 | -0.4505 | 0.0062 | -0.1659 | 0.0208 | 0.3346 | 1.17 | -- | -150.55 | -74.90 | -454.68 | -102.81 | 13.12 | 3.61 | -7,256.77 | -8,974.20 | 0.0726 | -9.28 | 6.94 | -- | 37.04 | 313.06 | 20.63 | -- | -- | -- |
